DrugsControl Media Services
DrugsControl.org

News Detail

AstraZeneca reaffirms safety of Covishield, Vaxzevria vaccines amid blood clot concerns (02-05-2024)

Cambridge, 2 May 2024: Amid recent concerns over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reaffirmed its dedication to patient safety, while underscoring its overall safety profile.

An AstraZeneca spokesperson......
View Details

Source : ANI
AstraZeneca Covid vaccine Covid vaccines Vaxzevria Covishield Thrombosis Thrombocytopenia Syndrome TTS

Related News